CompaniesInnaVirVax

InnaVirVax

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

138

By Phase

PHASE1/PHASE2: 2PHASE2: 1

By Status

UNKNOWN: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
Today
NCT01549119
NCT02041247
NCT02390466
Hover over trial bars to see details

Recent Trials

NCT02390466Lead Sponsor
Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1
PHASE1/PHASE2Unknown
15 participants
Started: Apr 30, 2015 · Completed: Apr 30, 2017
NCT02041247Lead Sponsor
Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection
PHASE2Unknown
90 participants
Started: Jan 31, 2014 · Completed: Nov 30, 2016
NCT01549119Lead Sponsor
Phase I/IIa Dose-escalation Clinical Study of VAC-3S
PHASE1/PHASE2Completed
33 participants
Started: Feb 29, 2012 · Completed: Dec 31, 2014